Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Frontiers in Physiology|June 9, 2020
PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular DystrophyAndrea Farini, Chiara Villa, Dario Di Silvestre, et al.Journal of Clinical Medicine|February 12, 2020
Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic HealthElena Dozio, Elena Vianello, Clementina Sitzia, et al.Experimental Cell Research|April 3, 2012
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal modelAndrea Farini, Clementina Sitzia, Claire Navarro, et al.International Journal of Molecular Sciences|February 11, 2023
Unveiling IL-33/ST2 Pathway Unbalance in Cardiac Remodeling Due to Obesity in Zucker Fatty RatsClementina Sitzia, Elena Vianello, Elena Dozio, et al.Biomed Research International|April 11, 2015
Improvement of endurance of DMD animal model using natural polyphenolsClementina Sitzia, Andrea Farini, Federica Colleoni, et al.Nature Communications|April 9, 2021
Defective dystrophic thymus determines degenerative changes in skeletal muscleAndrea Farini, Clementina Sitzia, Chiara Villa, et al.International Journal of Nanomedicine|July 13, 2012
Novel insight into stem cell trafficking in dystrophic musclesAndrea Farini, Chiara Villa, Adrian Manescu, et al.The Journal of Biological Chemistry|October 24, 2008
NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosisLuigi Anastasia, Nadia Papini, Francesca Colazzo, et al.The FEBS Journal|September 14, 2013
Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cellsMirella Meregalli, Claire Navarro, Clementina Sitzia, et al.The American Journal of Pathology|November 19, 2018
Fibrosis Rescue Improves Cardiac Function in Dystrophin-Deficient Mice and Duchenne Patient-Specific Cardiomyocytes by Immunoproteasome ModulationAndrea Farini, Aoife Gowran, Pamela Bella, et al.Pageof 3